BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24941241)

  • 1. Value of covered stents to improve patency of long-segment SFA revascularization.
    Beschorner U; Zeller T
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):473-6. PubMed ID: 24941241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of total endoluminal superficial femoral artery bypass.
    Gable D
    J Cardiovasc Surg (Torino); 2011 Oct; 52(5):683-700. PubMed ID: 21799474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.
    Jebran AF; Popov AF; Zenker D; Bireta C; Friedrich M; Danner BC; Bougioukas I; Schoendube FA; Stojanovic T
    Vasc Endovascular Surg; 2013 Oct; 47(7):502-6. PubMed ID: 23867203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
    Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
    Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
    Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
    Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial.
    Lensvelt MM; Holewijn S; Fritschy WM; Wikkeling OR; van Walraven LA; Wallis de Vries BM; Zeebregts CJ; Reijnen MM
    Trials; 2011 Jul; 12():178. PubMed ID: 21767371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis.
    Doomernik DE; Golchehr B; Lensvelt MM; Reijnen MM
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):447-57. PubMed ID: 22854524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery.
    Lensvelt MM; Wikkeling OR; Van Oostayen JA; Roukema JG; Zeebregts CJ; Reijnen MM
    Vasc Endovascular Surg; 2012 May; 46(4):338-41. PubMed ID: 22504512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DETOUR procedure: no more need for conventional bypass surgery?
    Krievins D; Savlovskis J; Ezite N; Hill A; Kisis K; Gedins M; Zellans E; Holden A
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):172-177. PubMed ID: 29327570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of the heparin-bonded Viabahn stent graft in femoropopliteal TASC C and D lesions with a covered stent length of minimum 25 cm.
    Uhl C; Dadras A; Reichmann F; Betz T; Zorger N; Toepel I; Steinbauer M
    Vascular; 2019 Oct; 27(5):553-559. PubMed ID: 30917750
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament.
    Calligaro KD; Balraj P; Moudgill N; Rao A; Dougherty MJ; Eisenberg J
    J Vasc Surg; 2013 Feb; 57(2):421-6. PubMed ID: 23058723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Eluting Stent Shows Similar Patency Results as Prosthetic Bypass in Patients with Femoropopliteal Occlusion in a Randomized Trial.
    Björkman P; Auvinen T; Hakovirta H; Romsi P; Turtiainen J; Manninen H; Venermo M
    Ann Vasc Surg; 2018 Nov; 53():165-170. PubMed ID: 29886215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.